Search the MBS

Standard Search

Advanced Search Search Tips

Enter keywords or item numbers below
Search Options

Results 11 to 20 of 25 matches

Category 5 - DIAGNOSTIC IMAGING SERVICES

61559

61559 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
22-Dec-2005
Schedule Fee Start Date:
01-Oct-2001

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

FDG PET study of the brain, performed for the evaluation of refractory epilepsy which is being evaluated for surgery (R)

Bulk bill incentive



Fee: $918.00 Benefit: 75% = $688.50 85% = $834.60

(See para IN.0.19 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61565

61565 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Jul-2011
Schedule Fee Start Date:
01-Oct-2001

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy. (R)

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

(See para IN.0.19 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61571

61571 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Jul-2011
Schedule Fee Start Date:
01-Oct-2001

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study, for the further primary staging of  patients with histologically proven carcinoma of the uterine cervix, at FIGO stage IB2 or greater by conventional staging, prior to planned radical radiation therapy or combined modality therapy with curative intent. (R)

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

Category 5 - DIAGNOSTIC IMAGING SERVICES

61575

61575 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Jul-2011
Schedule Fee Start Date:
01-Jul-2011

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study, for the further staging of patients with confirmed local recurrence of carcinoma of the uterine cervix considered suitable for salvage pelvic chemoradiotherapy or pelvic exenteration with curative intent. (R)

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

Category 5 - DIAGNOSTIC IMAGING SERVICES

61577

61577 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Sep-2009
Schedule Fee Start Date:
01-Oct-2001

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study, performed for the staging of proven oesophageal or GEJ carcinoma, in patients considered suitable for active therapy (R).

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

Category 5 - DIAGNOSTIC IMAGING SERVICES

61598

61598 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Sep-2009
Schedule Fee Start Date:
14-Jan-2002

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study performed for the staging of biopsy-proven newly diagnosed or recurrent head and neck cancer (R).

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

Category 5 - DIAGNOSTIC IMAGING SERVICES

61604

61604 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Sep-2009
Schedule Fee Start Date:
14-Jan-2002

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study performed for the evaluation of patients with suspected residual head and neck cancer after definitive treatment, and who are suitable for active therapy (R).

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

Category 5 - DIAGNOSTIC IMAGING SERVICES

61610

61610 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Sep-2009
Schedule Fee Start Date:
14-Jan-2002

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study performed for the evaluation of metastatic squamous cell carcinoma of unknown primary site involving cervical nodes (R).

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

Category 5 - DIAGNOSTIC IMAGING SERVICES

61620

61620 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Nov-2017
Schedule Fee Start Date:
01-Jul-2011

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study for the initial staging of newly diagnosed or previously untreated Hodgkin or non-Hodgkin lymphoma (R)

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

(See para IN.0.19 of explanatory notes to this Category)

Category 5 - DIAGNOSTIC IMAGING SERVICES

61622

61622 - Additional Information

Item Start Date:
01-Jul-2018
Description Start Date:
01-Nov-2017
Schedule Fee Start Date:
14-Jan-2002

Group
I4 - Nuclear Medicine Imaging
Subgroup
2 - PET

Whole body FDG PET study to assess response to first line therapy either during treatment or within three months of completing definitive first line treatment for Hodgkin or non-Hodgkin lymphoma (R)

Bulk bill incentive



Fee: $953.00 Benefit: 75% = $714.75 85% = $869.60

(See para IN.0.19 of explanatory notes to this Category)

Results 11 to 20 of 25 matches


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change